O	0	10	Regulation	Regulation	NN	B-NP
O	11	13	of	of	IN	B-PP
O	14	17	the	the	DT	B-NP
O	18	29	composition	composition	NN	I-NP
O	30	32	of	of	IN	B-PP
O	33	36	the	the	DT	B-NP
B-Cellular_component	37	50	extracellular	extracellular	JJ	I-NP
I-Cellular_component	51	57	matrix	matrix	NN	I-NP
O	58	60	by	by	IN	B-PP
O	61	64	low	low	JJ	B-NP
O	65	72	density	density	NN	I-NP
O	73	84	lipoprotein	lipoprotein	NN	I-NP
O	85	93	receptor	receptor	NN	I-NP
O	93	94	-	-	HYPH	B-VP
O	94	101	related	relate	VBN	B-NP
O	102	109	protein	protein	NN	I-NP
O	109	110	-	-	HYPH	B-NP
O	110	111	1	1	CD	I-NP
O	111	112	:	:	:	O
O	113	123	activities	activity	NNS	B-NP
O	124	129	based	base	VBN	B-VP
O	130	132	on	on	IN	B-PP
O	133	143	regulation	regulation	NN	B-NP
O	144	146	of	of	IN	B-PP
O	147	151	mRNA	mRNA	NN	B-NP
O	152	162	expression	expression	NN	I-NP
O	162	163	.	.	.	O

O	164	167	Low	Low	JJ	B-NP
O	168	175	density	density	NN	I-NP
O	176	187	lipoprotein	lipoprotein	NN	I-NP
O	188	196	receptor	receptor	NN	I-NP
O	196	197	-	-	HYPH	B-VP
O	197	204	related	relate	VBN	B-NP
O	205	212	protein	protein	NN	I-NP
O	212	213	-	-	HYPH	B-NP
O	213	214	1	1	CD	I-NP
O	215	216	(	(	(	O
O	216	219	LRP	LRP	NN	B-NP
O	219	220	-	-	HYPH	B-NP
O	220	221	1	1	CD	I-NP
O	221	222	)	)	)	O
O	223	225	is	be	VBZ	B-VP
O	226	227	a	a	DT	B-NP
O	228	237	catabolic	catabolic	JJ	I-NP
O	238	246	receptor	receptor	NN	I-NP
O	247	250	for	for	IN	B-PP
B-Cellular_component	251	264	extracellular	extracellular	JJ	B-NP
I-Cellular_component	265	271	matrix	matrix	NN	I-NP
O	272	273	(	(	(	O
B-Cellular_component	273	276	ECM	ECM	NN	B-NP
O	276	277	)	)	)	O
O	278	288	structural	structural	JJ	B-NP
O	289	297	proteins	protein	NNS	I-NP
O	298	301	and	and	CC	B-PP
O	302	305	for	for	IN	B-PP
O	306	314	proteins	protein	NNS	B-NP
O	315	319	that	that	WDT	B-NP
O	320	324	bind	bind	VBP	B-VP
O	325	327	to	to	TO	B-PP
B-Cellular_component	328	331	ECM	ECM	NN	B-NP
O	331	332	.	.	.	O

O	333	336	LRP	LRP	NN	B-NP
O	336	337	-	-	HYPH	B-NP
O	337	338	1	1	CD	I-NP
O	339	343	also	also	RB	B-ADVP
O	344	346	is	be	VBZ	B-VP
O	347	357	implicated	implicate	VBN	I-VP
O	358	360	in	in	IN	B-PP
O	361	369	integrin	integrin	NN	B-NP
O	370	380	maturation	maturation	NN	I-NP
O	380	381	.	.	.	O

O	382	384	In	In	IN	B-PP
O	385	389	this	this	DT	B-NP
O	390	395	study	study	NN	I-NP
O	395	396	,	,	,	O
O	397	399	we	we	PRP	B-NP
O	400	407	applied	apply	VBD	B-VP
O	408	409	a	a	DT	B-NP
O	410	420	proteomics	proteomic	NNS	I-NP
O	421	429	strategy	strategy	NN	I-NP
O	430	432	to	to	TO	B-VP
O	433	441	identify	identify	VB	I-VP
O	442	447	novel	novel	JJ	B-NP
O	448	456	proteins	protein	NNS	I-NP
O	457	465	involved	involve	VBN	B-VP
O	466	468	in	in	IN	B-PP
B-Cellular_component	469	472	ECM	ECM	NN	B-NP
O	473	481	modeling	modeling	NN	I-NP
O	482	486	that	that	WDT	B-NP
O	487	490	are	be	VBP	B-VP
O	491	500	regulated	regulate	VBN	I-VP
O	501	503	by	by	IN	B-PP
O	504	507	LRP	LRP	NN	B-NP
O	507	508	-	-	HYPH	B-NP
O	508	509	1	1	CD	I-NP
O	509	510	.	.	.	O

O	511	513	We	We	PRP	B-NP
O	514	518	show	show	VBP	B-VP
O	519	523	that	that	IN	B-SBAR
O	524	527	LRP	LRP	NN	B-NP
O	527	528	-	-	HYPH	B-NP
O	528	529	1	1	CD	I-NP
O	530	540	deficiency	deficiency	NN	I-NP
O	541	543	in	in	IN	B-PP
O	544	550	murine	murine	JJ	B-NP
B-Cell	551	560	embryonic	embryonic	JJ	I-NP
I-Cell	561	572	fibroblasts	fibroblast	NNS	I-NP
O	573	574	(	(	(	O
B-Cell	574	578	MEFs	MEF	NNS	B-NP
O	578	579	)	)	)	O
O	580	582	is	be	VBZ	B-VP
O	583	593	associated	associate	VBN	I-VP
O	594	598	with	with	IN	B-PP
O	599	608	increased	increase	VBN	B-NP
O	609	615	levels	level	NNS	I-NP
O	616	618	of	of	IN	B-PP
O	619	623	type	type	NN	B-NP
O	624	627	III	III	CD	I-NP
O	628	636	collagen	collagen	NN	I-NP
O	637	640	and	and	CC	I-NP
O	641	648	pigment	pigment	NN	I-NP
O	649	659	epithelium	epithelium	NN	I-NP
O	659	660	-	-	HYPH	O
O	660	667	derived	derive	VBN	B-NP
O	668	674	factor	factor	NN	I-NP
O	674	675	,	,	,	O
O	676	681	which	which	WDT	B-NP
O	682	692	accumulate	accumulate	VBP	B-VP
O	693	695	in	in	IN	B-PP
O	696	699	the	the	DT	B-NP
B-Cellular_component	700	710	substratum	substratum	NN	I-NP
O	711	722	surrounding	surround	VBG	B-VP
B-Cell	723	728	cells	cell	NNS	B-NP
O	728	729	.	.	.	O

O	730	733	The	The	DT	B-NP
O	734	742	collagen	collagen	NN	I-NP
O	743	751	receptor	receptor	NN	I-NP
O	751	752	,	,	,	O
O	753	757	uPAR	uPAR	NN	B-NP
O	757	758	-	-	HYPH	B-NP
O	758	760	AP	AP	NN	I-NP
O	760	761	/	/	SYM	B-NP
O	761	765	Endo	Endo	NN	I-NP
O	765	766	-	-	HYPH	B-NP
O	766	769	180	180	CD	I-NP
O	769	770	,	,	,	O
O	771	773	is	be	VBZ	B-VP
O	774	778	also	also	RB	I-VP
O	779	788	increased	increase	VBN	I-VP
O	789	791	in	in	IN	B-PP
O	792	795	LRP	LRP	NN	B-NP
O	795	796	-	-	HYPH	B-NP
O	796	797	1	1	CD	I-NP
O	797	798	-	-	HYPH	I-NP
O	798	807	deficient	deficient	JJ	I-NP
B-Cell	808	812	MEFs	MEF	NNS	I-NP
O	812	813	.	.	.	O

O	814	819	Human	Human	JJ	B-NP
O	820	823	LRP	LRP	NN	I-NP
O	823	824	-	-	HYPH	B-NP
O	824	825	1	1	CD	I-NP
O	826	834	reversed	reverse	VBD	B-VP
O	835	838	the	the	DT	B-NP
O	839	846	changes	change	NNS	I-NP
O	847	849	in	in	IN	B-PP
O	850	857	protein	protein	NN	B-NP
O	858	868	expression	expression	NN	I-NP
O	869	879	associated	associate	VBN	B-VP
O	880	884	with	with	IN	B-PP
O	885	888	LRP	LRP	NN	B-NP
O	888	889	-	-	HYPH	B-NP
O	889	890	1	1	CD	I-NP
O	891	901	deficiency	deficiency	NN	I-NP
O	901	902	;	;	:	O
O	903	910	however	however	RB	B-ADVP
O	910	911	,	,	,	O
O	912	915	the	the	DT	B-NP
O	916	925	endocytic	endocytic	JJ	I-NP
O	926	934	activity	activity	NN	I-NP
O	935	937	of	of	IN	B-PP
O	938	941	LRP	LRP	NN	B-NP
O	941	942	-	-	HYPH	B-NP
O	942	943	1	1	CD	I-NP
O	944	947	was	be	VBD	B-VP
O	948	951	not	not	RB	I-VP
O	952	960	involved	involve	VBN	I-VP
O	960	961	.	.	.	O

O	962	969	Instead	Instead	RB	B-ADVP
O	969	970	,	,	,	O
O	971	981	regulation	regulation	NN	B-NP
O	982	990	occurred	occur	VBD	B-VP
O	991	993	at	at	IN	B-PP
O	994	997	the	the	DT	B-NP
O	998	1002	mRNA	mRNA	NN	I-NP
O	1003	1008	level	level	NN	I-NP
O	1008	1009	.	.	.	O

O	1010	1020	Inhibition	Inhibition	NN	B-NP
O	1021	1023	of	of	IN	B-PP
O	1024	1025	c	c	NN	B-NP
O	1025	1026	-	-	HYPH	I-NP
O	1026	1029	Jun	Jun	NN	I-NP
O	1030	1035	amino	amino	JJ	I-NP
O	1035	1036	-	-	HYPH	I-NP
O	1036	1044	terminal	terminal	JJ	I-NP
O	1045	1051	kinase	kinase	NN	I-NP
O	1052	1053	(	(	(	O
O	1053	1056	JNK	JNK	NN	B-NP
O	1056	1057	)	)	)	O
O	1058	1065	blocked	block	VBD	B-VP
O	1066	1070	type	type	NN	B-NP
O	1071	1074	III	III	CD	I-NP
O	1075	1083	collagen	collagen	NN	I-NP
O	1084	1094	expression	expression	NN	I-NP
O	1095	1097	in	in	IN	B-PP
O	1098	1101	LRP	LRP	NN	B-NP
O	1101	1102	-	-	HYPH	B-NP
O	1102	1103	1	1	CD	I-NP
O	1103	1104	-	-	HYPH	I-NP
O	1104	1113	deficient	deficient	JJ	I-NP
B-Cell	1114	1118	MEFs	MEF	NNS	I-NP
O	1118	1119	,	,	,	O
O	1120	1130	suggesting	suggest	VBG	B-VP
O	1131	1141	regulation	regulation	NN	B-NP
O	1142	1144	of	of	IN	B-PP
O	1145	1148	JNK	JNK	NN	B-NP
O	1149	1157	activity	activity	NN	I-NP
O	1158	1160	as	as	IN	B-PP
O	1161	1162	a	a	DT	B-NP
O	1163	1172	mechanism	mechanism	NN	I-NP
O	1173	1175	by	by	IN	B-PP
O	1176	1181	which	which	WDT	B-NP
O	1182	1185	LRP	LRP	NN	B-VP
O	1185	1186	-	-	HYPH	O
O	1186	1187	1	1	CD	B-NP
O	1188	1196	controls	control	NNS	I-NP
O	1197	1201	mRNA	mRNA	NN	B-NP
O	1202	1212	expression	expression	NN	I-NP
O	1212	1213	.	.	.	O

O	1214	1217	The	The	DT	B-NP
O	1218	1225	ability	ability	NN	I-NP
O	1226	1228	of	of	IN	B-PP
O	1229	1232	LRP	LRP	NN	B-NP
O	1232	1233	-	-	HYPH	B-NP
O	1233	1234	1	1	CD	I-NP
O	1235	1237	to	to	TO	B-VP
O	1238	1246	regulate	regulate	VB	I-VP
O	1247	1257	expression	expression	NN	B-NP
O	1258	1260	of	of	IN	B-PP
O	1261	1264	the	the	DT	B-NP
O	1265	1272	factors	factor	NNS	I-NP
O	1273	1283	identified	identify	VBN	B-VP
O	1284	1288	here	here	RB	B-ADVP
O	1289	1297	suggests	suggest	VBZ	B-VP
O	1298	1299	a	a	DT	B-NP
O	1300	1304	role	role	NN	I-NP
O	1305	1308	for	for	IN	B-PP
O	1309	1312	LRP	LRP	NN	B-NP
O	1312	1313	-	-	HYPH	B-NP
O	1313	1314	1	1	CD	I-NP
O	1315	1317	in	in	IN	B-PP
O	1318	1329	determining	determine	VBG	B-VP
B-Multi-tissue_structure	1330	1335	blood	blood	NN	B-NP
I-Multi-tissue_structure	1336	1342	vessel	vessel	NN	I-NP
O	1343	1352	structure	structure	NN	I-NP
O	1353	1356	and	and	CC	B-PP
O	1357	1359	in	in	IN	B-PP
O	1360	1372	angiogenesis	angiogenesis	NN	B-NP
O	1372	1373	.	.	.	O

